InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the detailed record of transactions filed by Grissinger Michael. Director active across 1 company, notably Aprea Therapeutics, Inc.. In total, 3 reports have been published. History available since 28 July 2022. The latest transaction was filed on 20 June 2024 (Attribution). Regulator: SEC (Form 4). All data is free.
3 of 3 declarations